Logo image of SGBX

SAFE & GREEN HOLDINGS CORP (SGBX) Stock Fundamental Analysis

NASDAQ:SGBX - Nasdaq - US78418A6047 - Common Stock

0.9008  +0 (+0.1%)

After market: 0.88 -0.02 (-2.31%)

Fundamental Rating

1

SGBX gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 45 industry peers in the Construction & Engineering industry. SGBX may be in some trouble as it scores bad on both profitability and health. While showing a medium growth rate, SGBX is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year SGBX has reported negative net income.
In the past year SGBX has reported a negative cash flow from operations.
In the past 5 years SGBX always reported negative net income.
In the past 5 years SGBX always reported negative operating cash flow.
SGBX Yearly Net Income VS EBIT VS OCF VS FCFSGBX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 -5M -10M -15M -20M -25M

1.2 Ratios

SGBX has a Return On Assets of -303.91%. This is amonst the worse of the industry: SGBX underperforms 97.67% of its industry peers.
Industry RankSector Rank
ROA -303.91%
ROE N/A
ROIC N/A
ROA(3y)-71.69%
ROA(5y)-67.36%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
SGBX Yearly ROA, ROE, ROICSGBX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 200 -200 400 600

1.3 Margins

SGBX does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
SGBX Yearly Profit, Operating, Gross MarginsSGBX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -50 -100 -150 -200

More info and screens

0

2. Health

2.1 Basic Checks

SGBX does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for SGBX has been increased compared to 1 year ago.
SGBX has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, SGBX has a worse debt to assets ratio.
SGBX Yearly Shares OutstandingSGBX Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 200K 400K 600K 800K
SGBX Yearly Total Debt VS Total AssetsSGBX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M

2.2 Solvency

SGBX has an Altman-Z score of -18.42. This is a bad value and indicates that SGBX is not financially healthy and even has some risk of bankruptcy.
SGBX has a worse Altman-Z score (-18.42) than 97.67% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -18.42
ROIC/WACCN/A
WACC7.86%
SGBX Yearly LT Debt VS Equity VS FCFSGBX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 5M -5M 10M 15M 20M

2.3 Liquidity

SGBX has a Current Ratio of 0.15. This is a bad value and indicates that SGBX is not financially healthy enough and could expect problems in meeting its short term obligations.
The Current ratio of SGBX (0.15) is worse than 97.67% of its industry peers.
SGBX has a Quick Ratio of 0.15. This is a bad value and indicates that SGBX is not financially healthy enough and could expect problems in meeting its short term obligations.
SGBX has a worse Quick ratio (0.10) than 97.67% of its industry peers.
Industry RankSector Rank
Current Ratio 0.15
Quick Ratio 0.1
SGBX Yearly Current Assets VS Current LiabilitesSGBX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M 20M

More info and screens

5

3. Growth

3.1 Past

SGBX shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -18.57%.
SGBX shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -63.00%.
SGBX shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 15.07% yearly.
EPS 1Y (TTM)-18.57%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%60.39%
Revenue 1Y (TTM)-63%
Revenue growth 3Y23.57%
Revenue growth 5Y15.07%
Sales Q2Q%-56.17%

3.2 Future

SGBX is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 12.06% yearly.
SGBX is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 68.50% yearly.
EPS Next Y-3.1%
EPS Next 2Y12.06%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year103.81%
Revenue Next 2Y68.5%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
SGBX Yearly Revenue VS EstimatesSGBX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M
SGBX Yearly EPS VS EstimatesSGBX Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 -200 -400 -600

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for SGBX. In the last year negative earnings were reported.
Also next year SGBX is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
SGBX Price Earnings VS Forward Price EarningsSGBX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
SGBX Per share dataSGBX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -5 -10 -15 -20 -25

4.3 Compensation for Growth

SGBX's earnings are expected to grow with 12.06% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y12.06%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for SGBX!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

SAFE & GREEN HOLDINGS CORP

NASDAQ:SGBX (1/17/2025, 8:26:55 PM)

After market: 0.88 -0.02 (-2.31%)

0.9008

+0 (+0.1%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryConstruction & Engineering
Earnings (Last)11-22 2024-11-22/bmo
Earnings (Next)N/A N/A
Inst Owners10.42%
Inst Owner Change0%
Ins Owners25.88%
Ins Owner Change0%
Market Cap3.95M
Analysts82.86
Price TargetN/A
Short Float %7.79%
Short Ratio0.08
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-87.12%
Min Revenue beat(2)-89.09%
Max Revenue beat(2)-85.14%
Revenue beat(4)0
Avg Revenue beat(4)-87.48%
Min Revenue beat(4)-92.39%
Max Revenue beat(4)-83.27%
Revenue beat(8)0
Avg Revenue beat(8)-58.7%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.57
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-26.62
EYN/A
EPS(NY)-0.98
Fwd EYN/A
FCF(TTM)-2.9
FCFYN/A
OCF(TTM)-2.82
OCFYN/A
SpS1.57
BVpS-1.86
TBVpS-2.02
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -303.91%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-71.69%
ROA(5y)-67.36%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score1
Asset Turnover0.7
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 98.32%
Cap/Sales 4.84%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.15
Quick Ratio 0.1
Altman-Z -18.42
F-Score1
WACC7.86%
ROIC/WACCN/A
Cap/Depr(3y)537.79%
Cap/Depr(5y)480.39%
Cap/Sales(3y)10.3%
Cap/Sales(5y)9.78%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-18.57%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%60.39%
EPS Next Y-3.1%
EPS Next 2Y12.06%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-63%
Revenue growth 3Y23.57%
Revenue growth 5Y15.07%
Sales Q2Q%-56.17%
Revenue Next Year103.81%
Revenue Next 2Y68.5%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-2.17%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year37.62%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-62.48%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-138.94%
OCF growth 3YN/A
OCF growth 5YN/A